Medicare Expenditures in the First Year of Amyotrophic Lateral Sclerosis Diagnosis
Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.
